Insights+: The US FDA New Drug Approvals in August 2023
Shots: The US FDA approved 10 NDAs and 3 BLA in August 2023, leading to treatments...
New Drug Designations - August 2023
Shots: PharmaShots' designation report provides a concise overview...
Disease of the Month- Mesothelioma
Shots: To keep our readers acquainted with several disease conditions, ongoing trials,...
Insights+ Key Biosimilars Events of August 2023
Biosimilars are developed to be highly similar versions of approved biologics in terms of safety, purity, and...
Know Your Investor: RA Capital Management LLC
Shots: PharmaShots’ second dose of the Know Your Investor series focuses on...
Insights+: EMA Marketing Authorization of New Drugs in July 2023
Shots: The EMA approved 9 New Chemical Entity (NCE) and 5 Biologic Drugs in July 2...
